Clinical Trial Update: A Study of RSLV-132 in Subjects With Primary Sjogren's Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of RSLV-132 in subjects with primary Sjögren's syndrome has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjogren Syndrome

Drugs mentioned

• RSLV-132

Snippet

Sponsor: Resolve Therapeutics | Conditions: Sjogren's Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2021-04-02